Anaptysbio ANAB
NASDAQ ANAB
$48.02 +2.59 (+5.70%)
As of: Oct 21, 2026 · 10:23 AM EDT

Anaptysbio (ANAB) Non-Current Debt (2016 - 2019)

Updated

Anaptysbio's Non-Current Debt was $10 million in FY2016.

Analysis

Anaptysbio (ANAB) Non-Current Debt (2016 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 37.34 Bn
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 62.48 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn 60.50 Bn
10 Anaptysbio 1.38 Bn 264.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 3.10 Mn
Jun 30, 2019 4.80 Mn
Mar 31, 2019 6.50 Mn
Dec 31, 2018 625,000.00
Sep 30, 2018 2.41 Mn
Jun 30, 2018 4.12 Mn
Mar 31, 2018 5.83 Mn
Dec 31, 2017 7.55 Mn
Sep 30, 2017 9.27 Mn
Jun 30, 2017 10.99 Mn
Mar 31, 2017 12.71 Mn
Dec 31, 2016 13.81 Mn
API Access

Anaptysbio Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ANAB&period=max&api_key=YOUR_API_KEY